Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H21N3OS |
| Molecular Weight | 291.412 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(CN(CCN(C)C)C2=NC=CS2)C=C1
InChI
InChIKey=KYBJXENQEZJILU-UHFFFAOYSA-N
InChI=1S/C15H21N3OS/c1-17(2)9-10-18(15-16-8-11-20-15)12-13-4-6-14(19-3)7-5-13/h4-8,11H,9-10,12H2,1-3H3
| Molecular Formula | C15H21N3OS |
| Molecular Weight | 291.412 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17719807
Eight female pigs were anaesthetized byinitially intramuscular injection of a 1 ml mixture con-sisting of zolamine 5 mg/ml, butorphanol 1 mg/ml,ketamine 10 mg/ml and xylazin 2 mg/ml, followedby continuous intravenous infusion of propofol10 mg/kg per hour and fentanyl 0.025 mg/kg perhour throughout the operation.
Route of Administration:
Intramuscular
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:50:32 GMT 2025
by
admin
on
Mon Mar 31 17:50:32 GMT 2025
|
| Record UNII |
NXB79TB0N2
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Mon Mar 31 17:50:32 GMT 2025 , Edited by admin on Mon Mar 31 17:50:32 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID00203817
Created by
admin on Mon Mar 31 17:50:32 GMT 2025 , Edited by admin on Mon Mar 31 17:50:32 GMT 2025
|
PRIMARY | |||
|
Zolamine
Created by
admin on Mon Mar 31 17:50:32 GMT 2025 , Edited by admin on Mon Mar 31 17:50:32 GMT 2025
|
PRIMARY | |||
|
2353
Created by
admin on Mon Mar 31 17:50:32 GMT 2025 , Edited by admin on Mon Mar 31 17:50:32 GMT 2025
|
PRIMARY | |||
|
m539
Created by
admin on Mon Mar 31 17:50:32 GMT 2025 , Edited by admin on Mon Mar 31 17:50:32 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB00173MIG
Created by
admin on Mon Mar 31 17:50:32 GMT 2025 , Edited by admin on Mon Mar 31 17:50:32 GMT 2025
|
PRIMARY | |||
|
C81148
Created by
admin on Mon Mar 31 17:50:32 GMT 2025 , Edited by admin on Mon Mar 31 17:50:32 GMT 2025
|
PRIMARY | |||
|
CHEMBL127453
Created by
admin on Mon Mar 31 17:50:32 GMT 2025 , Edited by admin on Mon Mar 31 17:50:32 GMT 2025
|
PRIMARY | |||
|
100000078793
Created by
admin on Mon Mar 31 17:50:32 GMT 2025 , Edited by admin on Mon Mar 31 17:50:32 GMT 2025
|
PRIMARY | |||
|
14387
Created by
admin on Mon Mar 31 17:50:32 GMT 2025 , Edited by admin on Mon Mar 31 17:50:32 GMT 2025
|
PRIMARY | |||
|
553-13-9
Created by
admin on Mon Mar 31 17:50:32 GMT 2025 , Edited by admin on Mon Mar 31 17:50:32 GMT 2025
|
PRIMARY | |||
|
NXB79TB0N2
Created by
admin on Mon Mar 31 17:50:32 GMT 2025 , Edited by admin on Mon Mar 31 17:50:32 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |